Why Is Fosfomycin So Hard to Find? [Explained for 2026]

You have a urinary tract infection, your doctor sent in a prescription for fosfomycin (Monurol), and your pharmacy tells you they don't have it in stock. Sound familiar? You are not alone. While fosfomycin is not on the FDA's official drug shortage list in 2026, patients across the country regularly run into pharmacy-level availability gaps when trying to fill this antibiotic.

Understanding why this happens — and what you can do about it — can save you hours of frustration and get you the treatment you need faster. This guide breaks down the real reasons fosfomycin can be difficult to find, and the practical steps you can take today.

What Is Fosfomycin and Why Is It Prescribed?

Fosfomycin (brand name Monurol) is an antibiotic used to treat uncomplicated urinary tract infections in women. It belongs to a unique class of antibiotics called phosphonic acids and works by blocking the very first step bacteria need to build their cell walls. This mechanism is completely different from every other antibiotic on the market, which is why it remains effective against many drug-resistant bacteria.

What makes fosfomycin truly unique is its dosing: one single 3-gram packet mixed in water is all it takes to treat most uncomplicated UTIs. No multi-day regimen. No remembering to take pills twice a day. Just one dose. This convenience, combined with its effectiveness against resistant bacteria, makes it a popular choice — and that popularity can create stock challenges at smaller pharmacies.

Is Fosfomycin Currently in a National Shortage?

As of 2026, fosfomycin is not on the FDA Drug Shortage Database as an active national shortage. However, a drug not being on the shortage list does not mean it is easy to find at your local pharmacy. National availability and local pharmacy stock are very different things.

The FDA shortage list tracks manufacturer-level supply issues. Pharmacy-level gaps happen for entirely different reasons — lower ordering volumes, slow inventory turnover, and distributor allocation patterns that favor higher-demand medications.

Why Do Some Pharmacies Run Out of Fosfomycin?

Several factors contribute to pharmacy-level availability gaps for fosfomycin:

Slow inventory turnover: Because fosfomycin is a single-dose antibiotic, pharmacies sell one packet per prescription. Compare that to a 7-day antibiotic course — a pharmacy needs to sell seven times fewer prescriptions to keep fosfomycin in stock. This means small pharmacies may only order a handful of packets at a time and can run out quickly after just a few prescriptions.

Limited stock depth: Smaller independent pharmacies and some chain pharmacies in lower-volume areas may keep only 2-5 packets on hand at any given time.

Generic vs. brand confusion: A generic version of fosfomycin tromethamine is FDA-approved. However, some pharmacies stock only the brand name Monurol, or vice versa. If your prescription is written one way and the pharmacy stocks another, it may appear as an unavailability even when the drug is technically accessible.

Demand spikes: During periods when UTI prescriptions rise — such as summer months when UTIs are more common — demand can temporarily outpace a pharmacy's stock levels.

Distributor gaps: A pharmacy's distributor may be temporarily out of stock, even though manufacturers have adequate supply. These gaps typically resolve within days to a week.

Does the New IV Fosfomycin (Contepo) Affect Oral Availability?

In November 2025, the FDA approved an intravenous formulation of fosfomycin called Contepo, manufactured by Meitheal Pharmaceuticals, for complicated urinary tract infections in hospitalized patients. This IV product is completely separate from the oral fosfomycin packets you get at a retail pharmacy.

The two products use different formulations, are dispensed through different channels (hospital pharmacy vs. retail pharmacy), and draw from different supply chains. The introduction of Contepo should not affect the availability of oral fosfomycin at your local pharmacy.

What Should You Do If Your Pharmacy Doesn't Have It?

If your first pharmacy can't fill your fosfomycin prescription, here are the most effective next steps:

Call several pharmacies before giving up. Fosfomycin availability varies widely by location. A pharmacy two miles away may have it in stock while your usual pharmacy does not.

Ask your pharmacist to check with their distributor. If a pharmacy is out of stock, they can often order it and have it within 24-48 hours.

Ask about brand vs. generic interchangeability. If the pharmacy has the generic but not Monurol (or vice versa), confirm with your prescriber whether substitution is acceptable.

Use a pharmacy search service. medfinder calls pharmacies near you to check which ones have your medication in stock — saving you the time of making dozens of calls yourself.

Talk to your prescriber about alternatives. If fosfomycin truly isn't available nearby, nitrofurantoin (Macrobid) and trimethoprim-sulfamethoxazole (Bactrim) are IDSA-guideline first-line alternatives for uncomplicated UTIs.

How medfinder Can Help You Find Fosfomycin

Instead of spending your afternoon on hold with pharmacies, medfinder does the work for you. You provide your medication, dosage, and location. medfinder contacts pharmacies in your area to find out which ones can fill your prescription, then texts you the results. It is a paid service designed to save patients time and frustration when trying to locate medications like fosfomycin.

For more tips on locating fosfomycin at pharmacies near you, read our guide: How to Find Fosfomycin In Stock Near You (Tools + Tips)

The Bottom Line

Fosfomycin is not in a national shortage in 2026, but pharmacy-level availability gaps are real and common. The single-dose nature of the medication, combined with lower stocking volumes at many pharmacies, means you may need to check multiple locations to find it. The good news is that fosfomycin is manufactured in adequate quantities — it is usually just a matter of finding the pharmacy that has it in stock today.